Companies: 10,795·Total market cap: $144.5T
HLS Therapeutics Inc.

HLS Therapeutics Inc.

HLS.TOTSXHealthcare● Active
$4.40
$-0.07(-1.57%)
Market Cap$137604280
P/E Ratio—
52W High$5.765
52W Low$0.001
Overview

HLS Therapeutics Inc.（HLS.TO）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

hls.to · 股价预测 · 1 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 1 位华尔街分析师

SellBuy

Hold

1 位分析师

共识

评级分布

Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
合计: 1 · 买入占比: 0.0%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $4.40

HLS Therapeutics Inc.（HLS.TO）的分析师共识为 Hold，基于过去 3 个月内 1 位华尔街分析师的评级。HLS.TO 的 12 个月平均目标价为 $0.00，相对当前价 $4.40 代表 +0.0% 的潜在上行空间。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$4.32↓ 1.87%

1-day model range: $4.31–$4.33. Peak: $4.33 (-1.87%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$4-8.7%
2028$4-12.7%
2029$4-14.6%
2030$4-15.6%
2031—-16.0%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)39.7Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · HLS.TO · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$4.43SELL
MA 10$4.49SELL
MA 20$4.56SELL
MA 50$4.56SELL
MA 100$4.53SELL
MA 200$4.88SELL
Current $HLS.TO · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$4.44SELL
EMA 10$4.48SELL
EMA 20$4.53SELL
EMA 50$4.56SELL
EMA 100$4.61SELL
EMA 200$4.67SELL
Current $HLS.TO · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Raymond James2024-03-18
Maintains
Market Perform→Market Perform
Raymond James2021-08-06
Downgrade ↓
Outperform→Market Perform

Wall Street analysts have recently issued updated ratings on HLS Therapeutics Inc. (HLS.TO) stock. Of the recent 2 rating actions, 0 were upgrades and 1 were downgrades. 1 analysts currently cover HLS.TO.

分析师推荐趋势

Buy ratings0 → 0
Hold ratings1 → 1
Sell ratings0 → 0

HLS.TO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$58M

↓ 24.8% YoY

Revenue Next Year

$64M

↑ 10.8% YoY

EPS This Year

$-0.27

EPS Next Year

$-0.03

↓ 88.9% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast HLS.TO EPS of $-0.27 for the current fiscal year, based on estimates from 2 analysts. The HLS.TO revenue forecast is $58M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

HLS.TO 股价预测由两类独立数据源支撑：来自 1 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。HLS.TO 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Hold。

HLS.TO 的短期预测（明日）为 $4.32（-1.87%）。 HLS.TO 对 2027 年的股价预测均值为 $4。 HLS.TO 对 2030 年的预测区间为 $4–$4。

HLS Therapeutics Inc. 在 TSX 上市，代码 HLS.TO。HLS.TO 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 0% 对应 Hold 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

相关页面

盈利营收市盈率财务报表市值内幕交易股息价格历史

常见问题

HLS.TO 预测 · 8 个问题

根据 1 位华尔街分析师，HLS.TO 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $4.40，隐含约 +0.0% 的上行空间。

HLS.TO 目标价HLS.TO 分析师目标价HLS.TO 12个月目标价目标价 HLS.TO

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.